Does ELRANATAMAB Cause C-reactive protein increased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of C-reactive protein increased have been filed in association with ELRANATAMAB (Elrexfio). This represents 0.7% of all adverse event reports for ELRANATAMAB.
5
Reports of C-reactive protein increased with ELRANATAMAB
0.7%
of all ELRANATAMAB reports
1
Deaths
4
Hospitalizations
How Dangerous Is C-reactive protein increased From ELRANATAMAB?
Of the 5 reports, 1 (20.0%) resulted in death, 4 (80.0%) required hospitalization.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELRANATAMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ELRANATAMAB Cause?
Cytokine release syndrome (131)
Immune effector cell-associated neurotoxicity syndrome (44)
Death (42)
Pyrexia (42)
Pneumonia (40)
Cytomegalovirus infection (34)
Neutropenia (30)
Covid-19 (29)
Infection (28)
Cytomegalovirus infection reactivation (24)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which ELRANATAMAB Alternatives Have Lower C-reactive protein increased Risk?
ELRANATAMAB vs ELRANATAMAB-BCMM
ELRANATAMAB vs ELTROMBOPAG
ELRANATAMAB vs ELTROMBOPAG OLAMINE
ELRANATAMAB vs ELUXADOLINE
ELRANATAMAB vs ELVITEGRAVIR